Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

National Post-market Clinical Follow-up Study to Evaluate in Real-world Practice the Efficacy and Safety of Granulocytoapheresis and Its Impact on Quality of Life in Patients With Inflammatory Bowel Disease

NCT05636709 is registered in ClinicalTrials.gov with Adacyte Therapeutics SL as lead sponsor.

NCT NCT05636709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05636709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
National Post-market Clinical Follow-up Study to Evaluate in Real-world Practice the Efficacy and Safety of Granulocytoapheresis and Its Impact on Quality of Life in Patients With Inflammatory Bowel Disease
Lead sponsor
Adacyte Therapeutics SL
Phase
Observational
Overall status
Recruiting
Start date
January 11, 2022
Completion date
June 30, 2026
Enrollment
350 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, ulcerative colitis